hit counter

Olanzapine for Anorexia: A Promising Treatment Both Systemically & Intranasally (2023 Study)

Anorexia nervosa (AN), a severe mental disorder characterized by an intense fear of gaining weight and a distorted body image, remains a formidable challenge in psychiatric treatment. Recent research has shone a light on the potential of olanzapine, an atypical antipsychotic, in offering new hope through both systemic and innovative intranasal administration methods in animal …

Read more

Brain Biomarkers in Suicide Attempts: Elevated 5-HT1A Heteroreceptors & Hyperactivity in Superior Temporal Gyrus (2023 Review)

Suicide, a tragic end to around 800,000 lives each year, remains one of the most perplexing and devastating phenomena in mental health. Despite the vast number of studies and data, accurately predicting who is at risk of suicide has remained largely elusive, with current tools heavily reliant on subjective assessments and the clinician’s experience. A …

Read more

Quetiapine-Induced Psychosis: A Rare Adverse Effect (2024 Case Report)

Quetiapine, a second-generation antipsychotic medication, is renowned for its efficacy in managing a spectrum of psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder (MDD). Despite its broad therapeutic utility and a generally favorable side effect profile, quetiapine’s role in rare instances of inducing psychotic symptoms warrants a closer examination. Highlights: Quetiapine’s Mechanism of …

Read more

Repetitive TMS for Alzheimer’s Disease Alters Brain Waves & Enhances Cognition (2024 Study)

Repetitive transcranial magnetic stimulation (rTMS) is making waves in the field of Alzheimer’s disease (AD) research, offering a glimmer of hope for enhancing cognitive functions in patients. By targeting specific brain regions, rTMS has shown promising results in modulating neural activity and improving cognitive scores. This innovative therapy, coupled with real-time monitoring through electroencephalography (EEG), …

Read more

Gene Editing with CRISPR/Cas9 to Treat Corticosteroid-Induced Neuropsychiatric Disorders (2023 Review)

The widespread use of corticosteroids (CCSs) across the globe for treating inflammatory conditions has led to an increased incidence of corticosteroid-induced neuropsychiatric disorders (NPDs), raising significant public health concerns. These disorders range from depression and anxiety to severe cognitive changes, challenging the medical community to find effective treatments. The exploration of genetic and epigenetic factors …

Read more

Effect of A Short Nap on Cognitive Function & Brain Connectivity with Sleep Deprivation (2023 Study)

Sleep deprivation (SD) is a common issue in today’s fast-paced world, leading to temporary cognitive impairments that can significantly affect daily functioning. However, new research reveals that even a short nap following a period of SD can help reverse these impairments to some extent, shedding light on the brain’s remarkable ability to recover. Highlights: Cognitive …

Read more

PGAM5 Genetics & Depression via ATP Levels in the Prefrontal Cortex (2023 Mouse Study)

Major depressive disorder (MDD) is a complex and prevalent psychiatric condition that affects millions worldwide, yet its underlying mechanisms remain only partially understood. Recent research sheds light on the critical roles of phosphoglycerate mutase family member 5 (PGAM5) and adenosine triphosphate (ATP) in the brain, offering new insights into how disruptions in energy metabolism can …

Read more